Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic Leukemia
NCT01556386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2014-07-14
Summary
This study is to find out distribution of genetic polymorphisms and genes related to the chemotherapeutic drugs of ALL.
Conditions
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Principal Investigators
-
Hyoung Jin Kang, MD. PhD. · Seoul National University Hospital
Eligibility
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-06-30
- Primary Completion
- 2012-03-31
- Completion
- 2012-05-31
Countries
- South Korea
Study Locations
More Related Trials
-
Genotyping Analysis of Acute Lymphoblastic Leukemia
NCT00961285 ·Status: UNKNOWN
-
Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia
NCT00003291 ·Status: COMPLETED
-
Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
NCT05512169 ·Status: RECRUITING
-
DNA Analysis of Tumor Tissue Samples From Young Patients With Acute Lymphoblastic Leukemia
NCT00897507 ·Status: COMPLETED
-
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT01185886 ·Status: UNKNOWN
-
Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan
NCT00526084 ·Status: UNKNOWN
-
Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia
NCT01533168 ·Status: COMPLETED
-
Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid Leukemia
NCT01150656 ·Status: COMPLETED
-
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
NCT00003861 ·Status: ACTIVE_NOT_RECRUITING
-
Genomic Changes in Childhood Acute Lymphoblastic Leukemia
NCT01089907 ·Status: UNKNOWN
-
Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia
NCT01505699 ·Status: COMPLETED
-
Exploring the Effect of Calaspargase Pegol on the Coagulation System in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients: Pilot Study
NCT07071051 ·Status: RECRUITING
-
Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421
NCT01035307 ·Status: COMPLETED
-
Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia
NCT01826214 ·Status: COMPLETED ·Phase: PHASE2
-
Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia
NCT01057290 ·Status: COMPLETED
-
A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
NCT01035216 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Efficacy Study of Idarubicin Dose Intensification to Treat Acute Myeloid Leukemia
NCT01518556 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Determinants of Mercaptopurine Toxicity in Paediatric Acute Lymphoblastic Leukemia Maintenance Therapy
NCT03920813 ·Status: UNKNOWN ·Phase: PHASE4
-
RNA Biomarkers in Tissue Samples From Infants With Acute Myeloid Leukemia
NCT01229124 ·Status: COMPLETED
-
Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia
NCT01540578 ·Status: COMPLETED
-
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
NCT00866281 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Studying Genes in Samples From Younger Patients With Acute Megakaryoblastic Leukemia
NCT01642069 ·Status: COMPLETED
-
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia
NCT00898092 ·Status: UNKNOWN
-
Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia
NCT01229956 ·Status: COMPLETED
-
A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia
NCT05189639 ·Status: RECRUITING